Tema ETFs’s Corvus Pharmaceuticals CRVS Stock Holding History

Tema ETFs’s Portfolio CRVS Stock Details CRVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.04M	Buy	136,276 +28,501	+26%	+$396K	0.07%	185
2026 Q1	$1.58M	Buy	107,775 +28,077	+35%	+$448K	0.11%	176
2025 Q4	$614K	Buy	79,698 +20,496	+35%	+$162K	0.05%	326
2025 Q3	$436K	Buy	+59,202	New	+$303K	0.04%	401

Other funds holding CRVS

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

AIM

Avity Investment Management Greenwich, Connecticut $1.57B AUM 35.56% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Tema ETFs's CRVS Position: Q2 2026 in Review

Tema ETFs increased its Corvus Pharmaceuticals (CRVS) stake by 26% in Q2 2026, buying an estimated $396K and bringing the position to 136,276 shares worth $2.04M. The position accounts for 0.07% of the portfolio, ranked #185.

Tema ETFs first reported a position in CRVS in Q3 2025 and has held it in 4 quarters since. 8 funds tracked by Wall St. Rank hold CRVS as of Q2 2026.

Tema ETFs held 136,276 shares of Corvus Pharmaceuticals worth $2.04M as of Q2 2026.
Tema ETFs bought 28,501 Corvus Pharmaceuticals shares in Q2 2026, an estimated $396K.
Corvus Pharmaceuticals made up 0.07% of Tema ETFs's portfolio in Q2 2026, its #185 holding.
Tema ETFs first reported a position in Corvus Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
8 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.